Research
Hormonal
GLP-1 analogs may interact with estrogens.
Consideration of estrogen interactions may be important in treatment plans involving GLP-1 analogs.
StrongSupportsmedium confidence
an interaction of these therapeutics with estrogens
Why this rating
The claim is supported by a review of existing literature.
Source
GLP-1 and Its Analogs: Does Sex Matter?
Stina Börchers et al. · Endocrinology · 2024
DOI 10.1210/endocr/bqae165
reviewCited 58×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →